Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

Comments

Popular posts from this blog

Oppo K11 5G With Snapdragon 782G SoC, 100W Fast Charging Launched: Price, Specifications